id
stringlengths 1
5
| question_id
stringlengths 1
5
| document_id
stringlengths 5
7
| question
stringlengths 55
970
| type
stringclasses 1
value | choices
list | context
stringlengths 0
971
| answer
sequence |
---|---|---|---|---|---|---|---|
9500 | 13140 | 3525331 | Compared to placebo what was the result of Chinese herbal ChuanXiong Ding Tong herbal formula granule (CXDT-HFG) on proportion of patients with a reduction of migraine days by at least 50%? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | In other words, the mean reduction of migraine days in the CXDT-HFG group were 3.04 days, compared with 2.20 days in the placebo group at 12 weeks (95% CI, −4.13 to −1.93 versus 95% CI, −3.74 to −0.66; P = 0.033) | [
"significantly decreased"
] |
9501 | 13141 | 3525331 | Compared to placebo what was the result of Chinese herbal ChuanXiong Ding Tong herbal formula granule (CXDT-HFG) on frequency of migraine attacks? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | In other words, the mean reduction of migraine days in the CXDT-HFG group were 3.04 days, compared with 2.20 days in the placebo group at 12 weeks (95% CI, −4.13 to −1.93 versus 95% CI, −3.74 to −0.66; P = 0.033) | [
"significantly decreased"
] |
9502 | 13142 | 3525331 | Compared to placebo what was the result of Chinese herbal ChuanXiong Ding Tong herbal formula granule (CXDT-HFG) on attack frequency? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | In other words, the mean reduction of migraine days in the CXDT-HFG group were 3.04 days, compared with 2.20 days in the placebo group at 12 weeks (95% CI, −4.13 to −1.93 versus 95% CI, −3.74 to −0.66; P = 0.033) | [
"significantly decreased"
] |
9503 | 13143 | 3525331 | Compared to placebo what was the result of Chinese herbal ChuanXiong Ding Tong herbal formula granule (CXDT-HFG) on The number of patients using acute pain drugs, such as aspirin, phenacetin, or ibuprofen, etc.? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | In other words, the mean reduction of migraine days in the CXDT-HFG group were 3.04 days, compared with 2.20 days in the placebo group at 12 weeks (95% CI, −4.13 to −1.93 versus 95% CI, −3.74 to −0.66; P = 0.033) | [
"no significant difference"
] |
9504 | 13144 | 3672764 | Compared to SC placebo at baseline plus oral indomethacin as above what was the result of subcutaneous (SC) rilonacept 320 mg at baseline plus oral indomethacin 50 mg TID for 3 days followed by 25 mg TID for up to 9 days; on change in pain in the index joint? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Although primary endpoint pain reduction was greater with rilonacept plus indomethacin (-1.55 ± 0.92) relative to indomethacin alone (-1.40 ± 0.96), the difference was not statistically significant (P = 0.33), so formal comparison between monotherapy groups was not performed. | [
"no significant difference"
] |
9505 | 13145 | 3672764 | Compared to SC placebo at baseline plus oral indomethacin as above what was the result of subcutaneous (SC) rilonacept 320 mg at baseline plus oral indomethacin 50 mg TID for 3 days followed by 25 mg TID for up to 9 days; on Pain reduction? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Although primary endpoint pain reduction was greater with rilonacept plus indomethacin (-1.55 ± 0.92) relative to indomethacin alone (-1.40 ± 0.96), the difference was not statistically significant (P = 0.33), so formal comparison between monotherapy groups was not performed. | [
"no significant difference"
] |
9506 | 13146 | 3672764 | Compared to SC placebo at baseline plus oral indomethacin as above what was the result of SC rilonacept 320 mg at baseline plus oral placebo on Pain reduction according to the numerical rating scale (NRS)? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Although primary endpoint pain reduction was greater with rilonacept plus indomethacin (-1.55 ± 0.92) relative to indomethacin alone (-1.40 ± 0.96), the difference was not statistically significant (P = 0.33), so formal comparison between monotherapy groups was not performed. | [
"significantly increased"
] |
9507 | 13147 | 3672764 | Compared to SC rilonacept 320 mg at baseline plus oral placebo what was the result of subcutaneous (SC) rilonacept 320 mg at baseline plus oral indomethacin 50 mg TID for 3 days followed by 25 mg TID for up to 9 days on high sensitivity C-reactive protein (hs-CRP)? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Although primary endpoint pain reduction was greater with rilonacept plus indomethacin (-1.55 ± 0.92) relative to indomethacin alone (-1.40 ± 0.96), the difference was not statistically significant (P = 0.33), so formal comparison between monotherapy groups was not performed. | [
"significantly increased"
] |
9508 | 13148 | 4372550 | Compared to lightwand with WEI JET under direct laryngoscopy what was the result of lightwand only; lightwand under direct laryngoscopy; on the intubation time? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | .
Although the intubation time was significantly longer in the WEI group (110.8±18.3 s) than the LW group (63.3±27.5 s, p = 0.000) or DL group (66.7±29.4 s, p = 0.000 | [
"significantly decreased"
] |
9509 | 13149 | 4372550 | Compared to lightwand with WEI JET under direct laryngoscopy what was the result of lightwand only; on successful tracheal intubation attempts? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | .
Although the intubation time was significantly longer in the WEI group (110.8±18.3 s) than the LW group (63.3±27.5 s, p = 0.000) or DL group (66.7±29.4 s, p = 0.000 | [
"significantly increased"
] |
9510 | 13150 | 4372550 | Compared to lightwand under direct laryngoscopy; what was the result of lightwand only; on successful tracheal intubation attempts? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | .
Although the intubation time was significantly longer in the WEI group (110.8±18.3 s) than the LW group (63.3±27.5 s, p = 0.000) or DL group (66.7±29.4 s, p = 0.000 | [
"no significant difference"
] |
9511 | 13151 | 4188038 | Compared to placebo what was the result of alpha-linolenic acid (ALA), a medium-chained, plant-based omega-3 fatty acid (18:3) on ADHD symptoms and a computerized continuous performance functions test. ? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | No between-group difference was found in the changes of the various measures of ADHD symptoms throughout the study period | [
"no significant difference"
] |
9512 | 13156 | 4301466 | Compared to Placebo group (placebo and mesalazine) what was the result of Diosmectite group (diosmectite and mesalazine) on clinical responses? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There was no significant difference in clinical responses between the Diosmectite group and the Placebo group (P>0.05). | [
"no significant difference"
] |
9513 | 13157 | 4301466 | Compared to Placebo group (placebo and mesalazine) what was the result of Diosmectite group (diosmectite and mesalazine) on The defecation frequency? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There was no significant difference in clinical responses between the Diosmectite group and the Placebo group (P>0.05). | [
"no significant difference"
] |
9514 | 13158 | 5951872 | Compared to ‘usual care.’ what was the result of survivorship care plans (SCPs) on experienced symptoms, concerns about the illness? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Significantly more endometrial patients in the SCP care arm compared to the usual care arm reported high experienced symptoms (18% vs 9%, p = 0.02) and high concerns about the illness (16% vs 7%, p = 0.02). | [
"significantly increased"
] |
9515 | 13159 | 5951872 | Compared to ‘usual care.’ what was the result of survivorship care plans (SCPs) on emotional impact of the disease? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Significantly more endometrial patients in the SCP care arm compared to the usual care arm reported high experienced symptoms (18% vs 9%, p = 0.02) and high concerns about the illness (16% vs 7%, p = 0.02). | [
"no significant difference"
] |
9516 | 13160 | 5951872 | Compared to ‘usual care.’ what was the result of survivorship care plans (SCPs) on trust that the treatment would help to cure the illness? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Significantly more endometrial patients in the SCP care arm compared to the usual care arm reported high experienced symptoms (18% vs 9%, p = 0.02) and high concerns about the illness (16% vs 7%, p = 0.02). | [
"no significant difference"
] |
9517 | 13161 | 5799990 | Compared to Group II was obturated at the first visit. subgroup IB and subgroup IIB, AH Plus sealer was used what was the result of Group I was medicated with ApexCal paste and obturated using the standardized protocol in second visit 7–10 days later. subgroup IA and subgroup IIA, obturation was done using Apexit Plus sealer on periapical healing evaluated by Kruskal–Wallis test? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | When scores obtained by radiographic evaluation were submitted to Kruskal–Wallis test, there was no statistically significant difference in periapical healing between teeth in subgroups IA, IB, IIA, and IIB at the baseline, 1-, 3-, or 6-month evaluation with P = 0.342, 0.839, 0.218, and 0.780, respectively | [
"no significant difference"
] |
9518 | 13162 | 5799990 | Compared to Group II was obturated at the first visit. subgroup IB and subgroup IIB, AH Plus sealer was used what was the result of Group I was medicated with ApexCal paste and obturated using the standardized protocol in second visit 7–10 days later. subgroup IA and subgroup IIA, obturation was done using Apexit Plus sealer on periapical healing evaluated by one-way ANOVA test? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | When scores obtained by radiographic evaluation were submitted to Kruskal–Wallis test, there was no statistically significant difference in periapical healing between teeth in subgroups IA, IB, IIA, and IIB at the baseline, 1-, 3-, or 6-month evaluation with P = 0.342, 0.839, 0.218, and 0.780, respectively | [
"no significant difference"
] |
9519 | 13167 | 5980435 | Compared to noncross‐matched blood type compatible pRBCs what was the result of received cross‐match and blood type compatible pRBCs on incidence of transfusion reactions? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | No significant difference in incidence of transfusion reactions between cross‐matched and noncross‐matched groups (CM+ 4/24; 17%, CM– 7/24; 29%, P = .16). | [
"no significant difference"
] |
9520 | 13168 | 5980435 | Compared to noncross‐matched blood type compatible pRBCs what was the result of received cross‐match and blood type compatible pRBCs on packed cell volume? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | No significant difference in incidence of transfusion reactions between cross‐matched and noncross‐matched groups (CM+ 4/24; 17%, CM– 7/24; 29%, P = .16). | [
"no significant difference"
] |
9521 | 13169 | 5827295 | Compared to split part-time occlusion what was the result of continuous occlusion on visual acuity’s improvement? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Best corrected visual acuity’s improvement was comparable between continuous and split part-time occlusion (0.20±0.27 vs 0.21±0.25; p = 0.79). | [
"no significant difference"
] |
9522 | 13171 | 5986584 | Compared to control group what was the result of WL program consisting of standard structured energy-restricted meal plans (1200–1500 Kcal/day) and physical activity on weight loss? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Subjects in the intervention group had significantly more weight loss (WL:−3.7 ± 0.5 kg; Control:−1.6 ± 0.5 kg; p=0.007) than the control group | [
"significantly increased"
] |
9523 | 13172 | 5986584 | Compared to control group what was the result of WL program consisting of standard structured energy-restricted meal plans (1200–1500 Kcal/day) and physical activity on total fat mass? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Subjects in the intervention group had significantly more weight loss (WL:−3.7 ± 0.5 kg; Control:−1.6 ± 0.5 kg; p=0.007) than the control group | [
"significantly decreased"
] |
9524 | 13173 | 5986584 | Compared to control group what was the result of WL program consisting of standard structured energy-restricted meal plans (1200–1500 Kcal/day) and physical activity on apoptotic or proliferation index? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Subjects in the intervention group had significantly more weight loss (WL:−3.7 ± 0.5 kg; Control:−1.6 ± 0.5 kg; p=0.007) than the control group | [
"no significant difference"
] |
9525 | 13174 | 5986584 | Compared to control group what was the result of WL program consisting of standard structured energy-restricted meal plans (1200–1500 Kcal/day) and physical activity on triglyceride and insulin level? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Subjects in the intervention group had significantly more weight loss (WL:−3.7 ± 0.5 kg; Control:−1.6 ± 0.5 kg; p=0.007) than the control group | [
"significantly decreased"
] |
9526 | 13175 | 5773985 | Compared to mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 μg buprenorphine (3 μg/kg)in group II what was the result of 0.5% bupivacaine with 1:200000 epinephrine in group I on mean volume of both the solutions used? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The difference in the mean volume of both the solutions used was found to be statistically nonsignificant (P = 0.84). | [
"no significant difference"
] |
9527 | 13176 | 5773985 | Compared to mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 μg buprenorphine (3 μg/kg)in group II what was the result of 0.5% bupivacaine with 1:200000 epinephrine in group I on subjective and objective onset of action? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The difference in the mean volume of both the solutions used was found to be statistically nonsignificant (P = 0.84). | [
"no significant difference"
] |
9528 | 13177 | 5773985 | Compared to mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 μg buprenorphine (3 μg/kg)in group II what was the result of 0.5% bupivacaine with 1:200000 epinephrine in group I on duration of surgical procedure? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The difference in the mean volume of both the solutions used was found to be statistically nonsignificant (P = 0.84). | [
"no significant difference"
] |
9529 | 13178 | 5773985 | Compared to mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 μg buprenorphine (3 μg/kg)in group II what was the result of 0.5% bupivacaine with 1:200000 epinephrine in group I on the mean duration of postoperative analgesia? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The difference in the mean volume of both the solutions used was found to be statistically nonsignificant (P = 0.84). | [
"significantly decreased"
] |
9530 | 13179 | 5773985 | Compared to mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 μg buprenorphine (3 μg/kg)in group II what was the result of 0.5% bupivacaine with 1:200000 epinephrine in group I on number of analgesic tablets? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The difference in the mean volume of both the solutions used was found to be statistically nonsignificant (P = 0.84). | [
"significantly increased"
] |
9531 | 13180 | 1190172 | Compared to covering letter a hand written signature what was the result of covering letter with either a computer printed signature on time to response? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Kaplan-Meier survival analysis was performed on time to response and no difference between the groups was detected (Log rank = 0.72, p = 0.39; Figure 2). | [
"no significant difference"
] |
9532 | 13181 | 5771543 | Compared to placebo what was the result of fluoxetine on CGI-I response rate? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | At week 8, the CGI-I response rate for fluoxetine (78.2%) was significantly greater compared with placebo (62.6%; p = 0.017). | [
"significantly increased"
] |
9533 | 13182 | 5771543 | Compared to placebo what was the result of desvenlafaxine on CGI-I response rate? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | At week 8, the CGI-I response rate for fluoxetine (78.2%) was significantly greater compared with placebo (62.6%; p = 0.017). | [
"no significant difference"
] |
9534 | 13183 | 5771543 | Compared to placebo what was the result of desvenlafaxine, fluoxetine on Treatment-emergent adverse events (TEAEs)? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | At week 8, the CGI-I response rate for fluoxetine (78.2%) was significantly greater compared with placebo (62.6%; p = 0.017). | [
"no significant difference"
] |
9535 | 13184 | 3269419 | Compared to SP+(3 d)AS what was the result of CQ+(3 d)AS; on gametocytaemia? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | By contrast, artesunate seemed as effective when combined with chloroquine as it was when combined with SP (MH-OR = 1.04, P = 0.83). | [
"significantly decreased"
] |
9536 | 13185 | 5722980 | Compared to mobile app designed to help with symptoms of anxiety in general (called Stress Free). what was the result of mobile app designed to target agoraphobia (called Agoraphobia Free) on symptom severity over time? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Both groups had statistically significant improvements in symptom severity over time (difference –5.97, 95% CI –8.49 to –3.44, P<.001 for Agoraphobia Free and –6.35, 95% CI –8.82 to –3.87, P<.001 for Stress Free), but there were no significant between-group differences on the primary outcome (difference 0.38, 95% CI –1.96 to 3.20, P=.64). | [
"no significant difference"
] |
9537 | 13186 | 5722980 | Compared to mobile app designed to help with symptoms of anxiety in general (called Stress Free). what was the result of mobile app designed to target agoraphobia (called Agoraphobia Free) on PAS: Panic and Agoraphobia Scale? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Both groups had statistically significant improvements in symptom severity over time (difference –5.97, 95% CI –8.49 to –3.44, P<.001 for Agoraphobia Free and –6.35, 95% CI –8.82 to –3.87, P<.001 for Stress Free), but there were no significant between-group differences on the primary outcome (difference 0.38, 95% CI –1.96 to 3.20, P=.64). | [
"no significant difference"
] |
9538 | 13187 | 3544627 | Compared to fast eating what was the result of slow eating on hunger at 5, 10, 15, 20 min? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Post hoc testing revealed that in the slow condition, hunger was significantly higher at 5, 10, 15, and 20min (p < 0.001) and was significantly lower at 60min (p = 0.003) compared with the fast condition, as shown in Figure 2A. | [
"significantly increased"
] |
9539 | 13188 | 3544627 | Compared to fast eating what was the result of slow eating on hunger at 60 min? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Post hoc testing revealed that in the slow condition, hunger was significantly higher at 5, 10, 15, and 20min (p < 0.001) and was significantly lower at 60min (p = 0.003) compared with the fast condition, as shown in Figure 2A. | [
"significantly decreased"
] |
9540 | 13189 | 3544627 | Compared to fast eating what was the result of slow eating on desire-to-eat at 5, 10, 15, 20 min? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Post hoc testing revealed that in the slow condition, hunger was significantly higher at 5, 10, 15, and 20min (p < 0.001) and was significantly lower at 60min (p = 0.003) compared with the fast condition, as shown in Figure 2A. | [
"significantly increased"
] |
9541 | 13190 | 3544627 | Compared to fast eating what was the result of slow eating on desire-to-eat at 60 min? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Post hoc testing revealed that in the slow condition, hunger was significantly higher at 5, 10, 15, and 20min (p < 0.001) and was significantly lower at 60min (p = 0.003) compared with the fast condition, as shown in Figure 2A. | [
"significantly decreased"
] |
9542 | 13191 | 3544627 | Compared to slow eating what was the result of fast eating on satiety at 5, 10, 15, 20 min? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Post hoc testing revealed that in the slow condition, hunger was significantly higher at 5, 10, 15, and 20min (p < 0.001) and was significantly lower at 60min (p = 0.003) compared with the fast condition, as shown in Figure 2A. | [
"significantly increased"
] |
9543 | 13192 | 3544627 | Compared to slow eating what was the result of fast eating on satiety at 60 min? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Post hoc testing revealed that in the slow condition, hunger was significantly higher at 5, 10, 15, and 20min (p < 0.001) and was significantly lower at 60min (p = 0.003) compared with the fast condition, as shown in Figure 2A. | [
"significantly decreased"
] |
9544 | 13193 | 3646783 | Compared to placebo what was the result of 30-months inhaled steroids treatment on percentage stained area of versican and collagen III? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | 30-Months inhaled steroids increased the percentage stained area of versican (9.6% [CI 0.9 to 18.3%]; p = 0.03) and collagen III (20.6% [CI 3.8 to 37.4%]; p = 0.02) compared to placebo. | [
"significantly increased"
] |
9545 | 13194 | 4702321 | Compared to placebo what was the result of ivacaftor (150 mg) on Respiratory Symptoms scale? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Respiratory Symptoms scale with a mean improvement of 5.9 points observed among patients receiving ivacaftor, exceeding the MCID value of 4 points, vs. a mean decline of 2.7 points among those receiving placebo (treatment effect of 8.6 points, P < 0.001) [12].Table 1 | [
"significantly increased"
] |
9546 | 13195 | 4702321 | Compared to placebo what was the result of ivacaftor (150 mg) on Physical Functioning , Health Perceptions, and Vitality? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Respiratory Symptoms scale with a mean improvement of 5.9 points observed among patients receiving ivacaftor, exceeding the MCID value of 4 points, vs. a mean decline of 2.7 points among those receiving placebo (treatment effect of 8.6 points, P < 0.001) [12].Table 1 | [
"significantly increased"
] |
9547 | 13196 | 5747107 | Compared to (iii) treatment as usual only what was the result of ESM-I consisting of six weeks of ESM combined with weekly feedback regarding the individual’s positive affective experiences on Hamilton Depression Rating Scale? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | At 32 weeks, mean HDRS score was three units lower in the ESM-I group than in the control group (after adjustment for baseline HDRS scores), which was statistically imprecise by conventional alpha (Table 3; B = −3.1, p = 0.051, intention-to-treat analysis). | [
"no significant difference"
] |
9548 | 13197 | 5747107 | Compared to (iii) treatment as usual only what was the result of ESM-I consisting of six weeks of ESM combined with weekly feedback regarding the individual’s positive affective experiences on symptomatic remission? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | At 32 weeks, mean HDRS score was three units lower in the ESM-I group than in the control group (after adjustment for baseline HDRS scores), which was statistically imprecise by conventional alpha (Table 3; B = −3.1, p = 0.051, intention-to-treat analysis). | [
"no significant difference"
] |
9549 | 13198 | 5747107 | Compared to (ii) six weeks of ESM without feedback, what was the result of ESM-I consisting of six weeks of ESM combined with weekly feedback regarding the individual’s positive affective experiences on rate of symptomatic remission? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | At 32 weeks, mean HDRS score was three units lower in the ESM-I group than in the control group (after adjustment for baseline HDRS scores), which was statistically imprecise by conventional alpha (Table 3; B = −3.1, p = 0.051, intention-to-treat analysis). | [
"no significant difference"
] |
9550 | 13199 | 3616744 | Compared to placebo what was the result of atomoxetine on relapse (defined as symptom return ≥ 90% of baseline in ADHD Rating Scale (ADHD-RS) total scores and ≥ 2 points on the CGI-Severity [CGI-S] scale)? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | At the 9-month study endpoint, 22.3% of subjects who continued with atomoxetine exhibited relapse (defined as symptom return ≥ 90% of baseline in ADHD Rating Scale (ADHD-RS) total scores and ≥ 2 points on the CGI-Severity [CGI-S] scale) compared to 37.9% of those given a placebo (P = 0.002) | [
"significantly decreased"
] |
9551 | 13200 | 3616744 | Compared to placebo what was the result of lisdexamfetamine dimesylate (LDX) on symptom relapse? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | At the 9-month study endpoint, 22.3% of subjects who continued with atomoxetine exhibited relapse (defined as symptom return ≥ 90% of baseline in ADHD Rating Scale (ADHD-RS) total scores and ≥ 2 points on the CGI-Severity [CGI-S] scale) compared to 37.9% of those given a placebo (P = 0.002) | [
"significantly decreased"
] |
9552 | 13201 | 5986495 | Compared to water (WAT), NNS-sweetened (NNS) what was the result of a sucrose-sweetened (SUC) drink on Plasma glucose and insulin concentrations? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Plasma glucose and insulin concentrations were significantly higher in SUC at T = 30 min (glucose: t17 = −3.77 and t17= −2.46; insulin: t17 = −3.94 and t17 = −5.11; all p < 0.05) as compared to WAT and NNS, respectively. | [
"significantly increased"
] |
9553 | 13202 | 5986495 | Compared to water (WAT), what was the result of a sucrose-sweetened (SUC) drink on Plasma ghrelin concentration? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Plasma glucose and insulin concentrations were significantly higher in SUC at T = 30 min (glucose: t17 = −3.77 and t17= −2.46; insulin: t17 = −3.94 and t17 = −5.11; all p < 0.05) as compared to WAT and NNS, respectively. | [
"significantly decreased"
] |
9554 | 13203 | 5986495 | Compared to water (WAT), what was the result of NNS-sweetened (NNS) on Plasma ghrelin concentration? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Plasma glucose and insulin concentrations were significantly higher in SUC at T = 30 min (glucose: t17 = −3.77 and t17= −2.46; insulin: t17 = −3.94 and t17 = −5.11; all p < 0.05) as compared to WAT and NNS, respectively. | [
"no significant difference"
] |
9555 | 13204 | 5986495 | Compared to water (WAT), NNS-sweetened (NNS) what was the result of a sucrose-sweetened (SUC) drink on Hunger ratings? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Plasma glucose and insulin concentrations were significantly higher in SUC at T = 30 min (glucose: t17 = −3.77 and t17= −2.46; insulin: t17 = −3.94 and t17 = −5.11; all p < 0.05) as compared to WAT and NNS, respectively. | [
"significantly decreased"
] |
9556 | 13205 | 5986495 | Compared to water (WAT) what was the result of NNS-sweetened (NNS) on Hunger ratings? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Plasma glucose and insulin concentrations were significantly higher in SUC at T = 30 min (glucose: t17 = −3.77 and t17= −2.46; insulin: t17 = −3.94 and t17 = −5.11; all p < 0.05) as compared to WAT and NNS, respectively. | [
"no significant difference"
] |
9557 | 13206 | 4745960 | Compared to standard trabeculectomy (TBC) what was the result of EX-PRESS P-50 implant on The mean of visual capacity? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The mean of visual capacity measured in logarithm of the minimum angle of resolution (logMAR), per group of treatment during the study period (1 day, 1 week, 1 month, 3, 6, and 12 months), showed on the first day a significant difference in visual acuity between the EX-PRESS P-50 and TBC groups, with P=0.049. | [
"significantly increased"
] |
9558 | 13207 | 4745960 | Compared to standard trabeculectomy (TBC) what was the result of EX-PRESS P-50 implant on Intraocular pressure? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The mean of visual capacity measured in logarithm of the minimum angle of resolution (logMAR), per group of treatment during the study period (1 day, 1 week, 1 month, 3, 6, and 12 months), showed on the first day a significant difference in visual acuity between the EX-PRESS P-50 and TBC groups, with P=0.049. | [
"no significant difference"
] |
9559 | 13208 | 4745960 | Compared to standard trabeculectomy (TBC) what was the result of EX-PRESS P-50 implant on Surgical success? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The mean of visual capacity measured in logarithm of the minimum angle of resolution (logMAR), per group of treatment during the study period (1 day, 1 week, 1 month, 3, 6, and 12 months), showed on the first day a significant difference in visual acuity between the EX-PRESS P-50 and TBC groups, with P=0.049. | [
"no significant difference"
] |
9560 | 13209 | 4745960 | Compared to standard trabeculectomy (TBC) what was the result of EX-PRESS P-50 implant on Surgical complications? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The mean of visual capacity measured in logarithm of the minimum angle of resolution (logMAR), per group of treatment during the study period (1 day, 1 week, 1 month, 3, 6, and 12 months), showed on the first day a significant difference in visual acuity between the EX-PRESS P-50 and TBC groups, with P=0.049. | [
"no significant difference"
] |
9561 | 13210 | 4681154 | Compared to group S - SNB with 20 ml of 0.375 % ropivacaine what was the result of group L - 100-ml injections of 0.2 % ropivacaine and 0.5 mg epinephrine to the surgical region on Numeric Rating Scale (NRS) score? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | NRS score changes were greater in group L than in group S (P < 0.01, ANOVA) and greater in group L than in group S at three postoperative time points: 3 h (P < 0.01), 6 h (P < 0.01), and 12 h (P = 0.013; Mann–Whitney U test). | [
"significantly increased"
] |
9562 | 13211 | 4681154 | Compared to group S - SNB with 20ml of 0.375% ropivacaine what was the result of group L - 100-ml injections of 0.2 ropivacaine and 0.5mg epinephrine to the surgical region on side effects? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | NRS score changes were greater in group L than in group S (P < 0.01, ANOVA) and greater in group L than in group S at three postoperative time points: 3 h (P < 0.01), 6 h (P < 0.01), and 12 h (P = 0.013; Mann–Whitney U test). | [
"no significant difference"
] |
9563 | 13212 | 4511442 | Compared to respiratory physiotherapy–driven weaning what was the result of progressive discontinuation of pressure support ventilation (PSV) with SmartCare™ on maximal inspiratory pressure, maximal expiratory pressure, forced vital capacity or rapid shallow breathing index? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There was no difference in maximal inspiratory pressure, maximal expiratory pressure, forced vital capacity or rapid shallow breathing index at the beginning of the weaning trial. | [
"no significant difference"
] |
9564 | 13213 | 4511442 | Compared to respiratory physiotherapy–driven weaning what was the result of progressive discontinuation of pressure support ventilation (PSV) with SmartCare™ on pressure support ventilation (PSV) and positive end-expiratory pressure (PEEP)? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There was no difference in maximal inspiratory pressure, maximal expiratory pressure, forced vital capacity or rapid shallow breathing index at the beginning of the weaning trial. | [
"significantly decreased"
] |
9565 | 13214 | 4511442 | Compared to respiratory physiotherapy–driven weaning what was the result of progressive discontinuation of pressure support ventilation (PSV) with SmartCare™ on Total duration of mechanical ventilation and extubation failure? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There was no difference in maximal inspiratory pressure, maximal expiratory pressure, forced vital capacity or rapid shallow breathing index at the beginning of the weaning trial. | [
"no significant difference"
] |
9566 | 13215 | 4511442 | Compared to respiratory physiotherapy–driven weaning what was the result of progressive discontinuation of pressure support ventilation (PSV) with SmartCare™ on Weaning duration? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There was no difference in maximal inspiratory pressure, maximal expiratory pressure, forced vital capacity or rapid shallow breathing index at the beginning of the weaning trial. | [
"significantly increased"
] |
9567 | 13216 | 4458006 | Compared to 2 cm distally, at the main bifurcation (group 2) what was the result of facial nerve transection and subsequent repair either at the main trunk of the nerve (group 1) on amplitude of whisking? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There was no statistically significant difference between the two groups at 2, 4, and 6 weeks after facial nerve surgery (p > 0.05). | [
"no significant difference"
] |
9568 | 13217 | 5816600 | Compared to non-ARB therapy what was the result of angiotensin II receptor blocker (ARB)-based antihypertensive therapy on urinary albumin/creatinine ratio (UACR)? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | UACR was significantly less in ARB group than in non-ARB group during follow-up period in patients with G3b and/or A3 (P = 0.0003), | [
"significantly decreased"
] |
9569 | 13219 | 5816600 | Compared to non-ARB therapy what was the result of angiotensin II receptor blocker (ARB)-based antihypertensive therapy on incidence of cardiovascular events? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | UACR was significantly less in ARB group than in non-ARB group during follow-up period in patients with G3b and/or A3 (P = 0.0003), | [
"significantly decreased"
] |
9570 | 13222 | 4752899 | Compared to placebo what was the result of praziquantel (60 mg/kg in split dose) on the percent change in S. japonicum (epg) from screening to 22 weeks gestation? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There was also a difference between groups in the percent change in S. japonicum (epg) from screening to 22 weeks gestation, though this did not reach statistical significance (−53.11 versus 128.7; P = 0.054). | [
"no significant difference"
] |
9571 | 13223 | 4752899 | Compared to placebo what was the result of praziquantel (60 mg/kg in split dose) on creatinine? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There was also a difference between groups in the percent change in S. japonicum (epg) from screening to 22 weeks gestation, though this did not reach statistical significance (−53.11 versus 128.7; P = 0.054). | [
"significantly increased"
] |
9572 | 13224 | 5983010 | Compared to control group what was the result of DHA supplementation group on Macular sensitivity? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Macular sensitivity increased from a mean (SD) of 25.9 (2.4) dB at baseline to 27.3 (2.3) dB at 90 days (P=0.030) in the DHA group only (between-group differences P<0.19). | [
"no significant difference"
] |
9573 | 13225 | 5983010 | Compared to control group what was the result of DHA supplementation group on The macular integrity index? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Macular sensitivity increased from a mean (SD) of 25.9 (2.4) dB at baseline to 27.3 (2.3) dB at 90 days (P=0.030) in the DHA group only (between-group differences P<0.19). | [
"significantly decreased"
] |
9574 | 13226 | 5735450 | Compared to air group what was the result of lignocaine group on Cuff pressure and volume achieved in the end of surgery? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Cuff pressure and volume achieved in the end of surgery were much higher in air group as compared to lignocaine group (P < 0.05). | [
"significantly decreased"
] |
9575 | 13227 | 5735450 | Compared to air group what was the result of lignocaine group on incidence of coughing? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Cuff pressure and volume achieved in the end of surgery were much higher in air group as compared to lignocaine group (P < 0.05). | [
"significantly decreased"
] |
9576 | 13228 | 5791588 | Compared to investigational TdaP (groups: T5d2aP1, T5d2aP2, T5d2aP4, T5d4aP1, T5d4aP2, T5d4aP4) what was the result of investigational aP (groups: aP1, aP2, and aP4), on pertussis toxin (PT)-specific PB? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Although there were no major differences across the 3 vaccine groups in percentage of participants with measurable frequencies of IgG-secreting PB, there was a significantly higher frequency of PT-specific PB in the high aP dose Tdap group than in the low-dose group (p < 0.0015 | [
"significantly increased"
] |
9577 | 13229 | 5791588 | Compared to T5d2aP1 group and T5d2aP4 what was the result of licensed TdaP comparator on IgG-secreting PB against filamentous hemagglutinin [FHA] antige? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Although there were no major differences across the 3 vaccine groups in percentage of participants with measurable frequencies of IgG-secreting PB, there was a significantly higher frequency of PT-specific PB in the high aP dose Tdap group than in the low-dose group (p < 0.0015 | [
"significantly increased"
] |
9578 | 13236 | 3540345 | Compared to watched the video what was the result of written information as a refresher on able to apply the technique? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The difference observed between those who had seen the video and those who had read up on the technique turned out to be an average of 6.19 points in favour of the first (P < 0.05) | [
"significantly increased"
] |
9579 | 13238 | 3611107 | Compared to placebo what was the result of Lactobacillus gasseri BNR17 on total cholesterol, high density lipoprotein, low density lipoprotein (LDL), and triglyceride? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | All serum lipids including total cholesterol, high density lipoprotein, low density lipoprotein (LDL), and triglyceride showed no significant clinical differences between the two groups. | [
"no significant difference"
] |
9580 | 13239 | 3611107 | Compared to placebo what was the result of Lactobacillus gasseri BNR17 on systolic or diastolic blood pressure, pulse rate? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | All serum lipids including total cholesterol, high density lipoprotein, low density lipoprotein (LDL), and triglyceride showed no significant clinical differences between the two groups. | [
"no significant difference"
] |
9581 | 13240 | 5644405 | Compared to filtration surgerie (tube) what was the result of filtration surgerie ( trabeculectomy) on The end-pressure difference (intraocular pressure at 60 minutes)? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The end-pressure difference (intraocular pressure at 60 minutes vs. baseline) was significantly greater in the tube group (5.6 ± 3.6 mmHg; 41% change) than in the trabeculectomy group (3.2 ± 4.7; 23% change; P = 0.03) | [
"significantly decreased"
] |
9582 | 13241 | 3686216 | Compared to home access to traditional electronic games what was the result of no home access to electronic games, on moderate/vigorous physical activity (MVPA)? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Table 1 shows that in comparison to traditional games, removal of all electronic games resulted in no significant change in daily MVPA over the whole week. | [
"no significant difference"
] |
9583 | 13242 | 3686216 | Compared to home access to traditional electronic games what was the result of active input games on sedentary time in the after-school period? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Table 1 shows that in comparison to traditional games, removal of all electronic games resulted in no significant change in daily MVPA over the whole week. | [
"significantly decreased"
] |
9584 | 13243 | 4784348 | Compared to standard intervention what was the result of invited to access the e-therapeutic platform (Next.Step) during 12 weeks in addition to the standard intervention on perceived benefits? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Multiple comparisons showed that, in general, the mean score of perceived benefits at 3 months was lower (M = 4.52; SD = .07) than the mean score at 0 months (M = 4.48; SD = .06), but there was no significant differences. | [
"no significant difference"
] |
9585 | 13245 | 4359698 | Compared to the walking and running CPETs what was the result of cycling maximal cardiopulmonary exercise testing (CPET) on The root mean square of successive R-R differences calculated for consecutive 30-s windows (rMSSD30s), heart rate recovery (HRR)? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Both HRR and rMSSD30s were significantly greater during recovery from the cycling CPET compared to the walking and running CPETs (P < 0.001). | [
"significantly increased"
] |
9586 | 13246 | 4359698 | Compared to the walking and running CPETs what was the result of cycling maximal cardiopulmonary exercise testing (CPET) on VO2peak, HRpeak, peak oxygen pulse, and energy expenditure? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Both HRR and rMSSD30s were significantly greater during recovery from the cycling CPET compared to the walking and running CPETs (P < 0.001). | [
"significantly decreased"
] |
9587 | 13247 | 5758845 | Compared to placebo what was the result of 3 g of Sipjeondaebo-tang on FAACT ACS? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | but the changes of FAACT ACS score were not significantly different between the two groups (p = 0.245) | [
"no significant difference"
] |
9588 | 13248 | 5758845 | Compared to placebo what was the result of 3 g of Sipjeondaebo-tang on anorexia VAS? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | but the changes of FAACT ACS score were not significantly different between the two groups (p = 0.245) | [
"no significant difference"
] |
9589 | 13249 | 5758845 | Compared to placebo what was the result of 3 g of Sipjeondaebo-tang on ACTH, cortisol, ghrelin, IL-6, ESR, and CRP? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | but the changes of FAACT ACS score were not significantly different between the two groups (p = 0.245) | [
"no significant difference"
] |
9590 | 13250 | 5758845 | Compared to placebo what was the result of 3 g of Sipjeondaebo-tang on qi deficiency scale and blood deficiency scale? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | but the changes of FAACT ACS score were not significantly different between the two groups (p = 0.245) | [
"no significant difference"
] |
9591 | 13251 | 5758845 | Compared to placebo what was the result of 3 g of Sipjeondaebo-tang on systolic blood pressure (SBP), diastolic blood pressure (DBP), pulse, AST, ALT, blood urea nitrogen (BUN), and creatinine? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | but the changes of FAACT ACS score were not significantly different between the two groups (p = 0.245) | [
"no significant difference"
] |
9592 | 13252 | 29053 | Compared to ventilated with a hydrophobic heat-moisture exchanger (HME) or a hygroscopic HME what was the result of ventilated with a heated humidifier (HH) on Total respiratory heat loss? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Total respiratory heat loss was significantly less with the HH than with either HME (P < 0.01) | [
"significantly decreased"
] |
9593 | 13253 | 29053 | Compared to ventilated with a hydrophobic heat-moisture exchanger (HME) or a hygroscopic HME what was the result of ventilated with a heated humidifier (HH) on inspired RH and AH over the 24-h ? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Total respiratory heat loss was significantly less with the HH than with either HME (P < 0.01) | [
"significantly increased"
] |
9594 | 13254 | 3598524 | Compared to endotracheal intubation what was the result of Combitube, EasyTube, I-Gel, Laryngeal Mask Airway and Laryngeal tube on The median of overall hands-off time? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The median of overall hands-off time was significantly higher for endotracheal intubation (39.4s; 95% CI 34.0-44.9s) compared to Laryngeal tube (6.1s; 5.2-6.9s), Combitube (7.9s; 6.9-9.0s), LMA (10.2s; 8.6-11.7s), EasyTube (8.8s; 7.3-10.3s), and I-Gel (11.9s; 10.2-13.7s) (Table 1). | [
"significantly decreased"
] |
9595 | 13255 | 3598524 | Compared to endotracheal intubation what was the result of Combitube, EasyTube, I-Gel, Laryngeal Mask Airway and Laryngeal tube on Mean number of attempts? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The median of overall hands-off time was significantly higher for endotracheal intubation (39.4s; 95% CI 34.0-44.9s) compared to Laryngeal tube (6.1s; 5.2-6.9s), Combitube (7.9s; 6.9-9.0s), LMA (10.2s; 8.6-11.7s), EasyTube (8.8s; 7.3-10.3s), and I-Gel (11.9s; 10.2-13.7s) (Table 1). | [
"significantly decreased"
] |
9596 | 13256 | 4527103 | Compared to received homeopathic syrup alone for 10 days what was the result of received homeopathic syrup for 10 days plus oral antibiotic treatment (amoxicillin/clavulanate, clarithromycin, and erythromycin) for 7 days on reduction of cough severity? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | with a non-significant difference in progressive reduction of cough severity between the two groups (Table 2). | [
"no significant difference"
] |
9597 | 13257 | 4527103 | Compared to received homeopathic syrup alone for 10 days what was the result of received homeopathic syrup for 10 days plus oral antibiotic treatment (amoxicillin/clavulanate, clarithromycin, and erythromycin) for 7 days on adverse events? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | with a non-significant difference in progressive reduction of cough severity between the two groups (Table 2). | [
"significantly increased"
] |
9598 | 13258 | 4527103 | Compared to received homeopathic syrup alone for 10 days what was the result of received homeopathic syrup for 10 days plus oral antibiotic treatment (amoxicillin/clavulanate, clarithromycin, and erythromycin) for 7 days on cough resolution? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | with a non-significant difference in progressive reduction of cough severity between the two groups (Table 2). | [
"no significant difference"
] |
9599 | 13259 | 3733617 | Compared to receive no pen what was the result of receive an attractive pen on The final response rate? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The final response rate for the intervention and control group were 61.9% and 46.8% respectively and was not statistically significant (Chi-square = 2.89, P = 0.089). | [
"no significant difference"
] |